Unknown

Dataset Information

0

The succinct synthesis of AT13387, a clinically relevant Hsp90 inhibitor.


ABSTRACT: AT13387 is an orally bioavailable clinical candidate developed to inhibit theheat shock protein 90 (Hsp90). This article describes a modified synthetic route for the multi-gram production of AT13387 in 46% overall yield. The modified synthetic route is short, avoids stringent reaction conditions and difficult purifications, which led to increase in an overall yield.

SUBMITTER: Kaur J 

PROVIDER: S-EPMC7577423 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

The succinct synthesis of AT13387, a clinically relevant Hsp90 inhibitor.

Kaur Jatinder J   Bhardwaj Atul A   Melancon Bruce J BJ   Blagg Brian S J BSJ  

Synthetic communications 20190423 11


AT13387 is an orally bioavailable clinical candidate developed to inhibit theheat shock protein 90 (Hsp90). This article describes a modified synthetic route for the multi-gram production of AT13387 in 46% overall yield. The modified synthetic route is short, avoids stringent reaction conditions and difficult purifications, which led to increase in an overall yield. ...[more]

Similar Datasets

| S-EPMC6641397 | biostudies-literature
| S-EPMC3154460 | biostudies-literature
| S-EPMC3992119 | biostudies-literature
| S-EPMC4742132 | biostudies-other
| S-EPMC3834878 | biostudies-literature
| S-EPMC10752118 | biostudies-literature
| S-EPMC4257954 | biostudies-literature
| S-EPMC4123816 | biostudies-literature
| S-EPMC4526352 | biostudies-literature
| S-EPMC4369176 | biostudies-literature